{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:32:42Z","timestamp":1793424762781,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007949","name":"Reumatikerf\u00f6rbundet","doi-asserted-by":"publisher","award":["R-664091"],"award-info":[{"award-number":["R-664091"]}],"id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003252","name":"Lunds Universitet","doi-asserted-by":"publisher","award":["ALFSKANE-446501"],"award-info":[{"award-number":["ALFSKANE-446501"]}],"id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hans and Birgitta Sundqvist Foundation","award":["01-015292593"],"award-info":[{"award-number":["01-015292593"]}]},{"name":"Lund University","id":[{"id":"https:\/\/ror.org\/012a77v79","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction\/Objective<\/jats:title>\n                    <jats:p>To estimate and compare the incidence of chronic obstructive pulmonary disease (COPD) in patients with spondyloarthritis (SpA) to matched population-based references.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with\u2009\u2265\u20091 SpA-diagnosis from an outpatient department of rheumatology\/internal medicine (\u2265\u200917\u00a0years at diagnosis) between January 1, 2000, and June 30, 2005, were identified in a regional healthcare register. From the same register, five controls without SpA-diagnosis were matched to each SpA-case on age at the first ever SpA-diagnosis for the case, municipality of residence at this time, and sex. SpA-cases and controls were followed from Jan 1, 2006, until first occurrence of either COPD (diagnosed in primary or secondary inpatient\/outpatient care), rheumatoid arthritis diagnosis, moving from the region, death, or Dec 31, 2018. The incidence rates of COPD in SpA-cases and controls, overall and by age-groups and sex, and the corresponding incidence rate ratios, were estimated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 1083\/4950 SpA-cases and controls were followed in the present study for 11,790.9\/58,876.4 person-years, with 38\/220 incident COPD-cases respectively. The estimated incidence of COPD in SpA-cases was 3.22 (95% CI 2.28\u20134.42) per 1000 person-years, with an incidence rate ratio compared to controls of 0.86 (95% CI 0.59\u20131.22). Similarly, there were no significant differences in the incidence of COPD in patients with SpA compared to controls in any age group and in both sexes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this register-based cohort study the incidence of COPD in patients with SpA was similar to that in matched population-based references, overall and after stratification for sex and age-groups.<\/jats:p>\n                    <jats:p>\n                      <jats:table-wrap>\n                        <jats:table>\n                          <jats:tbody>\n                            <jats:tr>\n                              <jats:td align=\"left\" colspan=\"2\">\n                                <jats:bold>Key Points<\/jats:bold>\n                                <jats:italic>\u2022\u00a0Spondyloarthritis (SpA) has been associated with comorbidities, e.g. cardiovascular disease. However, evidence regarding the relation between SpA and chronic obstructive pulmonary disease (COPD) is limited.<\/jats:italic>\n                                <jats:italic>\u2022\u00a0To our knowledge, this is the first study to investigate the incidence of COPD in a population-based cohort of patients with SpA in general and compare it to the background population.<\/jats:italic>\n                                <jats:italic>\u2022\u00a0Using a regional register of primary and specialized care, we found no difference in COPD incidence between those diagnosed with SpA and matched population-based references, overall and after stratification for sex and age group.<\/jats:italic>\n                                <jats:italic>\u2022\u00a0The results of the present study suggest that there may not be an association between SpA and COPD. However, further studies in other countries and settings are needed.<\/jats:italic>\n                              <\/jats:td>\n                            <\/jats:tr>\n                          <\/jats:tbody>\n                        <\/jats:table>\n                      <\/jats:table-wrap>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10067-026-08382-7","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T01:27:05Z","timestamp":1788312425000},"page":"6679-6687","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The incidence of clinically diagnosed chronic obstructive pulmonary disease in patients with spondyloarthritis compared to matched population-based references: a register-based study"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9261-7192","authenticated-orcid":false,"given":"Sofia","family":"Exarchou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5891-548X","authenticated-orcid":false,"given":"Ankita","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Zamout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3805-2290","authenticated-orcid":false,"given":"Carl","family":"Turesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"issue":"9783","key":"8382_CR1","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(11)60071-8","volume":"377","author":"M Dougados","year":"2011","unstructured":"Dougados M, Baeten D (2011) Spondyloarthritis. Lancet 377(9783):2127\u20132137. https:\/\/doi.org\/10.1016\/S0140-6736(11)60071-8","journal-title":"Lancet"},{"issue":"6","key":"8382_CR2","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landewe R et al (2009) The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68(6):777\u2013783. https:\/\/doi.org\/10.1136\/ard.2009.108233","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8382_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/ard.2010.133645","volume":"70","author":"M Rudwaleit","year":"2011","unstructured":"Rudwaleit M, van der Heijde D, Landewe R et al (2011) The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70(1):25\u201331. https:\/\/doi.org\/10.1136\/ard.2010.133645","journal-title":"Ann Rheum Dis"},{"issue":"9570","key":"8382_CR4","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","volume":"369","author":"J Braun","year":"2007","unstructured":"Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369(9570):1379\u20131390. https:\/\/doi.org\/10.1016\/S0140-6736(07)60635-7","journal-title":"Lancet"},{"key":"8382_CR5","doi-asserted-by":"publisher","unstructured":"van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361\u2013368. https:\/\/doi.org\/10.1002\/art.1780270401","DOI":"10.1002\/art.1780270401"},{"issue":"5\u20136","key":"8382_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1177\/1759720X18773726","volume":"10","author":"F Proft","year":"2018","unstructured":"Proft F, Poddubnyy D (2018) Ankylosing spondylitis and axial spondyloarthritis: recent insights and impact of new classification criteria. Ther Adv Musculoskelet Dis 10(5\u20136):129\u2013139. https:\/\/doi.org\/10.1177\/1759720X18773726","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"8382_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fmed.2018.00062","volume":"5","author":"A Molto","year":"2018","unstructured":"Molto A, Nikiphorou E (2018) Comorbidities in SPondyloarthritis. Front Med (Lausanne) 5:62. https:\/\/doi.org\/10.3389\/fmed.2018.00062","journal-title":"Front Med (Lausanne)"},{"issue":"Suppl4","key":"8382_CR8","doi-asserted-by":"publisher","first-page":"iv47","DOI":"10.1093\/rheumatology\/keaa246","volume":"59","author":"SS Zhao","year":"2020","unstructured":"Zhao SS, Robertson S, Reich T, Harrison NL, Moots RJ, Goodson NJ (2020) Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis. Rheumatology (Oxford) 59(Suppl4):iv47\u2013iv57. https:\/\/doi.org\/10.1093\/rheumatology\/keaa246","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"8382_CR9","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1136\/annrheumdis-2015-207688","volume":"75","author":"S Exarchou","year":"2016","unstructured":"Exarchou S, Lie E, Lindstrom U, Askling J, Forsblad-d\u2019Elia H, Turesson C, Kristensen LE, Jacobsson LT (2016) Mortality in ankylosing spondylitis: results from a nationwide population-based study. Ann Rheum Dis 75(8):1466\u20131472. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207688","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"8382_CR10","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/acr.23468","volume":"70","author":"E Nikiphorou","year":"2018","unstructured":"Nikiphorou E, Ramiro S, van der Heijde D, Norton S, Molto A, Dougados M, van den Bosch F, Landewe R, Assessment of SpondyloArthritis International Society Comorbidities in Spondyloarthritis Study Task F (2018) Association of comorbidities in spondyloarthritis with poor function, work disability, and quality of life: results from the Assessment of SpondyloArthritis International Society comorbidities in spondyloarthritis study. Arthritis Care Res (Hoboken) 70(8):1257\u20131262. https:\/\/doi.org\/10.1002\/acr.23468","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"8382_CR11","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.reuma.2017.03.011","volume":"14","author":"C Gonzalez","year":"2018","unstructured":"Gonzalez C, Curbelo Rodriguez R, Torre-Alonso JC et al (2018) Recommendations for the management of comorbidity in patients with axial spondyloarthritis in clinical practice. Reumatol Clin (Engl Ed) 14(6):346\u2013359. https:\/\/doi.org\/10.1016\/j.reuma.2017.03.011","journal-title":"Reumatol Clin (Engl Ed)"},{"issue":"2","key":"8382_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000762","volume":"4","author":"U Lindstrom","year":"2018","unstructured":"Lindstrom U, Olofsson T, Wedren S, Qirjazo I, Askling J (2018) Impact of extra-articular spondyloarthritis manifestations and comorbidities on drug retention of a first TNF-inhibitor in ankylosing spondylitis: a population-based nationwide study. RMD Open 4(2):e000762. https:\/\/doi.org\/10.1136\/rmdopen-2018-000762","journal-title":"RMD Open"},{"issue":"1","key":"8382_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/ar3699","volume":"14","author":"G Berdal","year":"2012","unstructured":"Berdal G, Halvorsen S, van der Heijde D, Mowe M, Dagfinrud H (2012) Restrictive pulmonary function is more prevalent in patients with ankylosing spondylitis than in matched population controls and is associated with impaired spinal mobility: a comparative study. Arthritis Res Ther 14(1):R19. https:\/\/doi.org\/10.1186\/ar3699","journal-title":"Arthritis Res Ther"},{"key":"8382_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ejim.2018.04.002","volume":"53","author":"K Sharif","year":"2018","unstructured":"Sharif K, Watad A, Tiosano S, Yavne Y, Blokh Kerpel A, Comaneshter D, Cohen AD, Amital H (2018) The link between COPD and ankylosing spondylitis: a population based study. Eur J Intern Med 53:62\u201365. https:\/\/doi.org\/10.1016\/j.ejim.2018.04.002","journal-title":"Eur J Intern Med"},{"issue":"2","key":"8382_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116608","volume":"10","author":"TC Shen","year":"2015","unstructured":"Shen TC, Lin CL, Wei CC, Chen CH, Tu CY, Hsia TC, Shih CM, Hsu WH, Sung FC (2015) The risk of asthma in patients with ankylosing spondylitis: a population-based cohort study. PLoS ONE 10(2):e0116608. https:\/\/doi.org\/10.1371\/journal.pone.0116608","journal-title":"PLoS ONE"},{"issue":"1","key":"8382_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-024-01335-x","volume":"24","author":"P Zamout","year":"2024","unstructured":"Zamout P, Exarchou S, Sharma A, Turesson C (2024) The prevalence of chronic obstructive pulmonary disease in patients with spondyloarthritis compared to the general population in the southernmost region of Sweden: a case-control study. Clin Exp Med 24(1):75. https:\/\/doi.org\/10.1007\/s10238-024-01335-x","journal-title":"Clin Exp Med"},{"issue":"2","key":"8382_CR17","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1183\/09031936.00070410","volume":"37","author":"K Hemminki","year":"2011","unstructured":"Hemminki K, Liu X, Ji J, Sundquist K, Sundquist J (2011) Subsequent COPD and lung cancer in patients with autoimmune disease. Eur Respir J 37(2):463\u2013465. https:\/\/doi.org\/10.1183\/09031936.00070410","journal-title":"Eur Respir J"},{"issue":"12","key":"8382_CR18","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1093\/rheumatology\/key224","volume":"57","author":"MJ Cook","year":"2018","unstructured":"Cook MJ, Bellou E, Bowes J, Sergeant JC, O\u2019Neill TW, Barton A, Verstappen SMM (2018) The prevalence of co-morbidities and their impact on physical activity in people with inflammatory rheumatic diseases compared with the general population: results from the UK Biobank. Rheumatology (Oxford) 57(12):2172\u20132182. https:\/\/doi.org\/10.1093\/rheumatology\/key224","journal-title":"Rheumatology (Oxford)"},{"issue":"10342","key":"8382_CR19","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1016\/S0140-6736(22)00470-6","volume":"399","author":"SA Christenson","year":"2022","unstructured":"Christenson SA, Smith BM, Bafadhel M, Putcha N (2022) Chronic obstructive pulmonary disease. Lancet 399(10342):2227\u20132242. https:\/\/doi.org\/10.1016\/S0140-6736(22)00470-6","journal-title":"Lancet"},{"key":"8382_CR20","unstructured":"Global Initiative for Chronic Obstructive Lung Disease - GOLD\u00a0(n.d.)\u00a0Global strategy for prevention, diagnosis and management of COPD: 2023 Report. https:\/\/goldcopd.org\/2023-gold-report-2\/ . Accessed 26 July 2026."},{"issue":"1","key":"8382_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-024-03051-2","volume":"26","author":"Z Wang","year":"2025","unstructured":"Wang Z, Lin J, Liang L, Huang F, Yao X, Peng K, Gao Y, Zheng J (2025) Global, regional, and national burden of chronic obstructive pulmonary disease and its attributable risk factors from 1990 to 2021: an analysis for the Global Burden of Disease Study 2021. Respir Res 26(1):2. https:\/\/doi.org\/10.1186\/s12931-024-03051-2","journal-title":"Respir Res"},{"issue":"1","key":"8382_CR22","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12931-019-1123-x","volume":"20","author":"Y Ma","year":"2019","unstructured":"Ma Y, Tong H, Zhang X, Wang M, Yang J, Wu M, Han R, Chen M, Hu X, Yuan Y, Pan G, Zou Y, Xu S, Pan F (2019) Chronic obstructive pulmonary disease in rheumatoid arthritis: a systematic review and meta-analysis. Respir Res 20(1):144. https:\/\/doi.org\/10.1186\/s12931-019-1123-x","journal-title":"Respir Res"},{"issue":"1","key":"8382_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2174\/1573397116666200905122757","volume":"17","author":"D Dejcman","year":"2021","unstructured":"Dejcman D, Skowasch D, Pizarro C, Krause A, Thomas D, Sch\u00e4fer VS (2021) Pulmonary manifestations of rheumatoid arthritis, psoriatic arthritis and peripheral spondyloarthritis: prevalence, diagnostic approach and treatment options. Curr Rheumatol Rev 17(1):17\u201328. https:\/\/doi.org\/10.2174\/1573397116666200905122757","journal-title":"Curr Rheumatol Rev"},{"issue":"1","key":"8382_CR24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1177\/1403494819868042","volume":"48","author":"S Lofvendahl","year":"2020","unstructured":"Lofvendahl S, Schelin MEC, Joud A (2020) The value of the Skane health-care register: prospectively collected individual-level data for population-based studies. Scand J Public Health 48(1):56\u201363. https:\/\/doi.org\/10.1177\/1403494819868042","journal-title":"Scand J Public Health"},{"key":"8382_CR25","unstructured":"Socialstyrelsen (n.d.) The Swedish prescribed drug register (PDR). https:\/\/www.socialstyrelsen.se\/statistik-och-data\/register\/lakemedelsregistret\/. Accessed 26 July 2026."},{"key":"8382_CR26","unstructured":"The Swedish Rheumatology Quality register (SRQ). http:\/\/srq.nu\/en\/. Accessed 26 July 2026"},{"key":"8382_CR27","unstructured":"Statistics Sweden. https:\/\/www.scb.se\/en\/. Accessed 26 July 2026"},{"issue":"8","key":"8382_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003172","volume":"3","author":"A Joud","year":"2013","unstructured":"Joud A, Stjerna J, Malmstrom EM, Westergren H, Petersson IF, Englund M (2013) Healthcare consultation and sick leave before and after neck injury: a cohort study with matched population-based references. BMJ Open 3(8):e003172. https:\/\/doi.org\/10.1136\/bmjopen-2013-003172","journal-title":"BMJ Open"},{"issue":"8","key":"8382_CR29","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s10654-016-0132-z","volume":"31","author":"N Terzikhan","year":"2016","unstructured":"Terzikhan N, Verhamme KM, Hofman A, Stricker BH, Brusselle GG, Lahousse L (2016) Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam study. Eur J Epidemiol 31(8):785\u2013792. https:\/\/doi.org\/10.1007\/s10654-016-0132-z","journal-title":"Eur J Epidemiol"},{"issue":"12","key":"8382_CR30","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.rmed.2011.06.012","volume":"105","author":"AS Afonso","year":"2011","unstructured":"Afonso AS, Verhamme KM, Sturkenboom MC, Brusselle GG (2011) COPD in the general population: prevalence, incidence and survival. Respir Med 105(12):1872\u20131884. https:\/\/doi.org\/10.1016\/j.rmed.2011.06.012","journal-title":"Respir Med"},{"key":"8382_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2024-002462","author":"AW Steinberg","year":"2025","unstructured":"Steinberg AW, Ozga JE, Tang Z, Stanton CA, Sargent JD, Paulin LM (2025) Gender, tobacco and chronic obstructive pulmonary disease: analysis of the 2020 National Health Interview Survey. BMJ Open Respir Res. https:\/\/doi.org\/10.1136\/bmjresp-2024-002462","journal-title":"BMJ Open Respir Res"},{"issue":"3","key":"8382_CR32","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1093\/eurpub\/ckae050","volume":"34","author":"B Jarvholm","year":"2024","unstructured":"Jarvholm B, Hedman L, Landstrom M, Liv P, Burdorf A, Toren K (2024) Changing smoking habits and the occurrence of lung cancer in Sweden-a population analysis. Eur J Public Health 34(3):566\u2013571. https:\/\/doi.org\/10.1093\/eurpub\/ckae050","journal-title":"Eur J Public Health"},{"issue":"6","key":"8382_CR33","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.arbres.2012.11.010","volume":"49","author":"J Ancochea","year":"2013","unstructured":"Ancochea J, Miravitlles M, Garcia-Rio F, Munoz L, Sanchez G, Sobradillo V, Duran-Tauleria E, Soriano JB (2013) Underdiagnosis of chronic obstructive pulmonary disease in women: quantification of the problem, determinants and proposed actions. Arch Bronconeumol 49(6):223\u2013229. https:\/\/doi.org\/10.1016\/j.arbres.2012.11.010","journal-title":"Arch Bronconeumol"},{"key":"8382_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2023.107347","volume":"217","author":"M Axelsson","year":"2023","unstructured":"Axelsson M, Backman H, Nwaru BI, Stridsman C, Vanfleteren L, Hedman L, Piirila P, Jalasto J, Langhammer A, Kankaanranta H, Radinger M, Ekerljung L, Ronmark E, Lindberg A (2023) Underdiagnosis and misclassification of COPD in Sweden - a Nordic Epilung study. Respir Med 217:107347. https:\/\/doi.org\/10.1016\/j.rmed.2023.107347","journal-title":"Respir Med"},{"issue":"6","key":"8382_CR35","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1136\/ard.2010.141598","volume":"70","author":"E Haglund","year":"2011","unstructured":"Haglund E, Bremander AB, Petersson IF, Strombeck B, Bergman S, Jacobsson LT, Turkiewicz A, Geborek P, Englund M (2011) Prevalence of spondyloarthritis and its subtypes in southern Sweden. Ann Rheum Dis 70(6):943\u2013948. https:\/\/doi.org\/10.1136\/ard.2010.141598","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"8382_CR36","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1080\/03009742.2022.2064183","volume":"52","author":"E Lindqvist","year":"2023","unstructured":"Lindqvist E, Olofsson T, Joud A, Geijer M, Wallman JK, Mogard E (2023) How good is the agreement between clinical diagnoses and classification criteria fulfilment in axial spondyloarthritis? Results from the SPARTAKUS cohort. Scand J Rheumatol 52(4):364\u2013373. https:\/\/doi.org\/10.1080\/03009742.2022.2064183","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"8382_CR37","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3109\/03009742.2015.1010572","volume":"44","author":"U Lindstrom","year":"2015","unstructured":"Lindstrom U, Exarchou S, Sigurdardottir V, Sundstrom B, Askling J, Eriksson JK, Forsblad-d\u2019Elia H, Turesson C, Kristensen LE, Jacobsson L (2015) Validity of ankylosing spondylitis and undifferentiated spondyloarthritis diagnoses in the Swedish National Patient Register. Scand J Rheumatol 44(5):369\u2013376. https:\/\/doi.org\/10.3109\/03009742.2015.1010572","journal-title":"Scand J Rheumatol"},{"issue":"7","key":"8382_CR38","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/rheumatology\/keaa093","volume":"59","author":"SS Zhao","year":"2020","unstructured":"Zhao SS, Goodson NJ, Robertson S, Gaffney K (2020) Smoking in spondyloarthritis: unravelling the complexities. Rheumatology (Oxford) 59(7):1472\u20131481. https:\/\/doi.org\/10.1093\/rheumatology\/keaa093","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"8382_CR39","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.semarthrit.2016.11.004","volume":"46","author":"V Villaverde-Garcia","year":"2017","unstructured":"Villaverde-Garcia V, Cobo-Ibanez T, Candelas-Rodriguez G, Seoane-Mato D, Campo-Fontecha PDD, Guerra M, Munoz-Fernandez S, Canete JD (2017) The effect of smoking on clinical and structural damage in patients with axial spondyloarthritis: a systematic literature review. Semin Arthritis Rheum 46(5):569\u2013583. https:\/\/doi.org\/10.1016\/j.semarthrit.2016.11.004","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"8382_CR40","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3899\/jrheum.210046","volume":"49","author":"S Exarchou","year":"2022","unstructured":"Exarchou S, Turesson C, Lindstrom U, Ramonda R, Landewe RB, Dagfinrud H, van Gaalen F, van der Heijde D, Jacobsson LT (2022) Lifestyle factors and disease activity over time in early axial spondyloarthritis: the spondyloarthritis caught early (SPACE) cohort. J Rheumatol 49(4):365\u2013372. https:\/\/doi.org\/10.3899\/jrheum.210046","journal-title":"J Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08382-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08382-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08382-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:05:36Z","timestamp":1793423136000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08382-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["8382"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08382-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"25 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Swedish Ethical Review Authority (September 23, 2000; registration number 2020\u201304041, with amendment on February 16, 2021; registration number 2021\u201300717). The Ethical Review Authority decided that individual informed consent was not necessary for this study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"S.E. has received speaker fees from Novartis and UCB Pharma, and consultancy fees from AbbVie, Amgen, Eli Lilly, Janssen, Novartis and UCB Pharma.\u00a0A.S. None declared.\u00a0P.Z. None declared.\u00a0C.T. has received speaker fees from AbbVie, Boehringer-Ingelheim, Nordic Drugs, Novartis and Pfizer, and consultancy fees from AbbVie, Boehringer-Ingelheim, Nordic Drugs and Novartis.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}